Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Cancer Research|August 18, 2004
Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcomeMartine E D Chamuleau, Yuri Souwer, S Marieke Van Ham, et al.
Cytometry. Part B, Clinical Cytometry|January 18, 2013
A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid originWillemijn van den Ancker, Theresia M Westers, David C de Leeuw, et al.
Haematologica|November 12, 2009
Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responsesMarvin M van Luijn, Martine E D Chamuleau, James A Thompson, et al.
Cytometry. Part B, Clinical Cytometry|February 18, 2022
A series of case studies illustrating the role of flow cytometry in the diagnostic work-up of myelodysplastic syndromesTheresia M Westers, Leonie Saft, Vincent H J van der Velden, et al.
Leukemia|February 15, 2023
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionMargot F van Spronsen, Diana Hanekamp, Theresia M Westers, et al.
Experimental Hematology|October 14, 2018
TCF4 promotes erythroid developmentFlorentien E M In 't Hout, Jolanda van Duren, Davide Monteferrario, et al.
Oncoimmunology|June 5, 2013
Priming of PRAME- and WT1-specific CD8+ T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapyWillemijn van den Ancker, Jurjen M Ruben, Theresia M Westers, et al.
Hemasphere|February 2, 2026
Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM-prognostic score (FCM-PS) for overall survivalAida Santaolalla, Uta Oelschlaegel, Susann Winter, et al.
Leukemia Research|April 16, 2014
High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemiaWillemijn van den Ancker, Marvin M van Luijn, Martine E D Chamuleau, et al.
Haematologica|February 9, 2012
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET studyMatteo G Della Porta, Cristina Picone, Cristiana Pascutto, et al.
Pageof 8